Experienced in Teratoma of the Mediastinum

Takuya J. Matsumoto

Sakai, JP 
Experienced in Teratoma of the Mediastinum
Sakai, JP 
OverviewLocationsClinical Research

Overview

Takuya Matsumoto practices in Sakai, Japan. Mr. Matsumoto is rated as an Experienced expert by MediFind in the treatment of Teratoma of the Mediastinum. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Rheumatoid Arthritis (RA), and Arthritis.

His clinical research consists of co-authoring 283 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Teratoma of the Mediastinum.

Gender
Male

Locations

Sakai, 5998531, Japan
Other Locations
Kyoto, Japan
Kobe, 6578501, Japan
Osaka, 5998531, Japan
Nishinomiya-hama, 6638179, Japan
Okayama, 7008525, Japan
Toon, Japan
Matsumoto, 3908621, Japan
Shizuoka, Japan
Wada, 6578501, Japan
Saitama, Japan
Wakayama, Japan
Hongo, 1130033, Japan
Kawasaki, Japan
Sayama, 3501394, Japan
Toyonaka, 5600043, Japan
Hiroshima, Japan
Japan
Chiyoda, Japan
Minami, 7348553, Japan
Arakawa, Japan
Tokyo, 1020083, Japan
Shinjuku, 1608582, Japan
Nagoya, 4668550, Japan
Zama, Japan
Himeji, Japan
Shobara, 7270023, Japan
Kawahara, 6068507, Japan
Niigata, 9503198, Japan
Katta, 7008525, Japan
Nankoku, 7838502, Japan
Katsura, 6158510, Japan
Shimotsuke, Japan
Yushima, 1138549, Japan
Tsukuba, 3058572, Japan
Suita, 5650871, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

282 Total Publications

Construction of yeast with extremely high 2,3-butanediol tolerance by introducing point and structural mutations and partial elucidation of the mechanism of 2,3-butanediol tolerance.
Construction of yeast with extremely high 2,3-butanediol tolerance by introducing point and structural mutations and partial elucidation of the mechanism of 2,3-butanediol tolerance.
Journal: Applied microbiology and biotechnology
Published: May 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Matsumoto's expertise for a condition
ConditionClose
      View All 32 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile